Feed SOMNF
SO

SomnoMed Limited SOMNF · OTC

$0.18 +0.00% (+$0.00)

Summary

65 / 100 · Bulios Score

What speaks for it

  • It holds more cash than debt: $17.2M against $5.45M.
  • The share price is below the Bulios Fair Price.
  • Revenue grew by 11% a year over the last 3 years.

What to watch

  • The company made a loss over the last 12 months.
  • Operating profit covers the interest on its debt only 2.1 times.
  • It missed profit estimates 4 times in the last 7 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $0.18

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

Yes, fast

Revenue (AUD)

Diluted EPS (AUD)

  • Analyst estimate

Revenue grew by 13% a year over 5 years. Over the last 3 years it grew by 11% a year.

Growth in detail

Does it make money?

Poorly

Over the last 12 months it made a loss of $2.65M.

Profitability in detail

Is it financially healthy?

Yes

Repaying all its debt would take 1.1 years of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy